Literature DB >> 8111724

Impact of adjuvant mitotane on the clinical course of patients with adrenocortical cancer.

A A Kasperlik-Załuska, B Migdalska, A Makowska.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8111724     DOI： 10.1002/1097-0142(19940301)73:5<1533::aid-cncr2820730536>3.0.co;2-g

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  2 in total

Review 1.  Current perspective in the diagnosis and treatment of adrenocortical carcinoma.

Authors:  D E Schteingart
Journal:  Rev Endocr Metab Disord       Date:  2001-08       Impact factor: 6.514

Review 2.  [Systemic therapy of malignant adrenal tumors].

Authors:  M Horstmann; A S Merseburger; A Stenzl; M Kuczyk
Journal:  Urologe A       Date:  2006-05       Impact factor: 0.639
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.